Future Positive Capital

The firm backs European seed and Series A companies applying advanced technologies to universal, planetary-scale challenges. Its thesis targets step-change solutions — defined as 10x to 100x improvements — in areas such as climate, energy, health and biology. Future Positive takes a problems-first, concentrated approach and leads or co-leads rounds.

Future Positive states that 100% of its carried interest is indexed on portfolio companies achieving both their financial and impact performance targets. This means the firm's long-term profit participation depends entirely on each venture meeting non-financial impact benchmarks alongside commercial success — a structural mechanism that legally binds GP compensation to the stated thesis.

Future Positive writes checks between €500,000 and €3 million at the seed or Series A stage. It leads or co-leads rounds and operates a concentrated portfolio, focusing on European companies that can create entirely new markets or fundamentally reshape large existing ones.

The firm's website references a founder, but no name is publicly disclosed on the site. Team pages and profiles return incomplete or placeholder information, leaving the lead investment decision-maker unidentified in available public materials.

The firm maintains offices in New York, Beverly Hills, Morristown, San Francisco, Los Angeles, Ross, Paris and London. Its investment mandate focuses on European companies, with sourcing and presence across both the United States and Europe.